CH620587A5 - - Google Patents

Download PDF

Info

Publication number: CH620587A5
Authority: CH; Switzerland
Prior art keywords: iodized; radical; composition according; organic compound; composition
Prior art date: 1976-05-07

Application number

CH572677A

Other languages

English (en)

French (fr)

Inventor

Janine Marissal-Benad

Original Assignee

Biotherm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-05-07

Filing date

1977-05-06

Publication date

1980-12-15

1977-05-06 Application filed by Biotherm filed Critical Biotherm

1980-12-15 Publication of CH620587A5 publication Critical patent/CH620587A5/fr

Links

239000000203 mixture Substances 0.000 claims description 39
150000002894 organic compounds Chemical class 0.000 claims description 14
125000004432 carbon atom Chemical group C* 0.000 claims description 10
229910052740 iodine Inorganic materials 0.000 claims description 10
239000011630 iodine Substances 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 9
229940011399 escin Drugs 0.000 claims description 8
125000004494 ethyl ester group Chemical group 0.000 claims description 8
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
108010032809 mucopolysaccharidase Proteins 0.000 claims description 8
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
108090000790 Enzymes Proteins 0.000 claims description 6
102000004190 Enzymes Human genes 0.000 claims description 6
239000002537 cosmetic Substances 0.000 claims description 6
238000009792 diffusion process Methods 0.000 claims description 6
239000001397 quillaja saponaria molina bark Substances 0.000 claims description 6
229930182490 saponin Natural products 0.000 claims description 6
-1 steroid backbone saponin Chemical class 0.000 claims description 5
229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
150000007949 saponins Chemical class 0.000 claims description 4
125000002345 steroid group Chemical group 0.000 claims description 4
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
229930186222 escin Natural products 0.000 claims description 3
230000003054 hormonal effect Effects 0.000 claims description 3
235000021388 linseed oil Nutrition 0.000 claims description 3
239000000944 linseed oil Substances 0.000 claims description 3
235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
239000008158 vegetable oil Substances 0.000 claims description 3
241000157282 Aesculus Species 0.000 claims description 2
101100295738 Gallus gallus COR3 gene Proteins 0.000 claims description 2
239000001888 Peptone Substances 0.000 claims description 2
108010080698 Peptones Proteins 0.000 claims description 2
CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
239000003513 alkali Substances 0.000 claims description 2
150000001342 alkaline earth metals Chemical class 0.000 claims description 2
125000005907 alkyl ester group Chemical group 0.000 claims description 2
125000000217 alkyl group Chemical group 0.000 claims description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
239000005018 casein Substances 0.000 claims description 2
235000021240 caseins Nutrition 0.000 claims description 2
235000014113 dietary fatty acids Nutrition 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
229930195729 fatty acid Natural products 0.000 claims description 2
239000000194 fatty acid Substances 0.000 claims description 2
150000004665 fatty acids Chemical class 0.000 claims description 2
125000005842 heteroatom Chemical group 0.000 claims description 2
235000010181 horse chestnut Nutrition 0.000 claims description 2
235000019319 peptone Nutrition 0.000 claims description 2
150000004670 unsaturated fatty acids Chemical class 0.000 claims description 2
235000021122 unsaturated fatty acids Nutrition 0.000 claims description 2
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
210000000689 upper leg Anatomy 0.000 description 13
210000001624 hip Anatomy 0.000 description 12
239000006071 cream Substances 0.000 description 11
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
208000035484 Cellulite Diseases 0.000 description 7
206010049752 Peau d'orange Diseases 0.000 description 7
150000001875 compounds Chemical class 0.000 description 7
239000003921 oil Substances 0.000 description 7
235000019198 oils Nutrition 0.000 description 7
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
230000036232 cellulite Effects 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
108010003272 Hyaluronate lyase Proteins 0.000 description 4
102000001974 Hyaluronidases Human genes 0.000 description 4
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
229960002773 hyaluronidase Drugs 0.000 description 4
238000005259 measurement Methods 0.000 description 4
239000002304 perfume Substances 0.000 description 4
229940068196 placebo Drugs 0.000 description 4
239000000902 placebo Substances 0.000 description 4
235000008753 Papaver somniferum Nutrition 0.000 description 3
240000001090 Papaver somniferum Species 0.000 description 3
235000021355 Stearic acid Nutrition 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
230000000694 effects Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000000499 gel Substances 0.000 description 3
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 3
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 3
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
229960002216 methylparaben Drugs 0.000 description 3
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
239000010491 poppyseed oil Substances 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
239000008117 stearic acid Substances 0.000 description 3
108010053474 thyroactive iodinated casein Proteins 0.000 description 3
229940099259 vaseline Drugs 0.000 description 3
ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
229960000541 cetyl alcohol Drugs 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
125000001481 periodyl group Chemical group *I(=O)(=O)=O 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000001593 sorbitan monooleate Substances 0.000 description 2
229940035049 sorbitan monooleate Drugs 0.000 description 2
235000011069 sorbitan monooleate Nutrition 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
CORFWQGVBFFZHF-UHFFFAOYSA-N 2-iodohippuric acid Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1I CORFWQGVBFFZHF-UHFFFAOYSA-N 0.000 description 1
FRPFEVLOFNAKBS-UHFFFAOYSA-N 3,5-diiodo-1h-pyridin-4-one Chemical compound IC1=CNC=C(I)C1=O FRPFEVLOFNAKBS-UHFFFAOYSA-N 0.000 description 1
ISDXXBVYCIDTIV-UHFFFAOYSA-N 3-(methylcarbamoyl)benzoic acid Chemical compound CNC(=O)C1=CC=CC(C(O)=O)=C1 ISDXXBVYCIDTIV-UHFFFAOYSA-N 0.000 description 1
125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
IAFQYUQIAOWKSB-UHFFFAOYSA-N Ethyl undecanoate Chemical compound CCCCCCCCCCC(=O)OCC IAFQYUQIAOWKSB-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 description 1
IWRUDYQZPTVTPA-UHFFFAOYSA-N Iophendylate Chemical compound CCOC(=O)CCCCCCCCC(C)C1=CC=CC=C1I IWRUDYQZPTVTPA-UHFFFAOYSA-N 0.000 description 1
YQNFBOJPTAXAKV-OMCISZLKSA-N Iopodic acid Chemical compound CN(C)\C=N\C1=C(I)C=C(I)C(CCC(O)=O)=C1I YQNFBOJPTAXAKV-OMCISZLKSA-N 0.000 description 1
UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
150000001491 aromatic compounds Chemical class 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000000975 dye Substances 0.000 description 1
235000006694 eating habits Nutrition 0.000 description 1
235000019441 ethanol Nutrition 0.000 description 1
239000006260 foam Substances 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
235000020721 horse chestnut extract Nutrition 0.000 description 1
229960002979 iopanoic acid Drugs 0.000 description 1
229940029393 iophendylate Drugs 0.000 description 1
GOIQOQCNFWYSTQ-UHFFFAOYSA-N iophenoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(O)=C1I GOIQOQCNFWYSTQ-UHFFFAOYSA-N 0.000 description 1
229950004657 iophenoic acid Drugs 0.000 description 1
TZADDXVKYWMEHX-UHFFFAOYSA-N iopydol Chemical compound OCC(O)CN1C=C(I)C(=O)C(I)=C1 TZADDXVKYWMEHX-UHFFFAOYSA-N 0.000 description 1
229960004146 iopydol Drugs 0.000 description 1
229950004833 iopydone Drugs 0.000 description 1
229960000929 iotalamic acid Drugs 0.000 description 1
229940029409 ipodate Drugs 0.000 description 1
XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
210000004197 pelvis Anatomy 0.000 description 1
VYAGDYWTCWDKIS-UHFFFAOYSA-N phenobutiodil Chemical compound CCC(C(O)=O)OC1=C(I)C=C(I)C=C1I VYAGDYWTCWDKIS-UHFFFAOYSA-N 0.000 description 1
229950009173 phenobutiodil Drugs 0.000 description 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940079033 protamone Drugs 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
ZEYOIOAKZLALAP-UHFFFAOYSA-M sodium amidotrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I ZEYOIOAKZLALAP-UHFFFAOYSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
210000001550 testis Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CH572677A 1976-05-07 1977-05-06 CH620587A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
LU74900A LU74900A1 (de)	1976-05-07	1976-05-07

Publications (1)

Publication Number	Publication Date
CH620587A5 true CH620587A5 (de)	1980-12-15

Family

ID=19728233

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH572677A CH620587A5 (de)	1976-05-07	1977-05-06

Country Status (11)

Country	Link
US (1)	US4187291A (de)
JP (1)	JPS539328A (de)
BE (1)	BE854358A (de)
CA (1)	CA1091581A (de)
CH (1)	CH620587A5 (de)
DE (1)	DE2720510C2 (de)
ES (1)	ES458559A1 (de)
FR (1)	FR2362635A1 (de)
GB (1)	GB1575217A (de)
IT (1)	IT1143808B (de)
LU (1)	LU74900A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2499405A1 (fr) *	1981-02-10	1982-08-13	Biotherm	Composition cosmetique amincissante et anti-cellulitique a base d'un extrait de plante contenant des saponines, un extrait d'arnica montana l. et d'un extrait de noix de cola et son procede d'application
US4389418A (en) *	1981-02-25	1983-06-21	S. C. Johnson & Son, Inc.	Skin care composition
JPS62156139U (de) *	1986-03-25	1987-10-03
US5102783A (en) *	1990-01-12	1992-04-07	Vetrepharm, Inc.	Composition and method for culturing and freezing cells and tissues
FR2669537B1 (fr) *	1990-11-28	1993-02-19	Oreal	Composition amincissante a base d'alpha-2-bloqueurs.
JPH04119660U (ja) *	1991-04-12	1992-10-26	東洋電機製造株式会社	回転電機の軸受け構造
ES2049661B1 (es) *	1992-10-09	1994-11-01	Imbeal S A Lab	Compuesto anticelulitico y proccedimiento de obtencion del mismo.
JP3615557B2 (ja) *	1993-09-07	2005-02-02	株式会社資生堂	抗色素沈着剤
JP3359774B2 (ja) *	1994-07-07	2002-12-24	株式会社資生堂	皮膚外用剤
US5827884A (en) *	1995-09-15	1998-10-27	Omp Acquisition Corporation	Skin peel maintenance composition and method
JP4881246B2 (ja) *	2007-07-13	2012-02-22	生化学工業株式会社	発毛効果増強剤
WO2021108751A1 (en) *	2019-11-26	2021-06-03	Standard Of Care Corporation	Hyaluronidase compositions and methods of using same to treat cellulite

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB609811A (en) *	1944-01-03	1948-10-07	Chem Ind Basel	Manufacture of improved cosmetic prepartions for the care of the skin
US3170916A (en) *	1961-02-23	1965-02-23	Chem Fab Tempelhof Preuss & Te	Method of producing durable saponine containing extracts from horse chestnut and products obtained therefrom
AT274250B (de) *	1968-04-17	1969-09-10	Nattermann & Cie Arzneimittel	Verfahren zur Gewinnung von wasserlöslichem Aescin aus Roßkastaniensamen und daraus hergestellten Extrakten

1976
- 1976-05-07 LU LU74900A patent/LU74900A1/xx unknown
1977
- 1977-05-04 JP JP5082077A patent/JPS539328A/ja active Pending
- 1977-05-05 GB GB18941/77A patent/GB1575217A/en not_active Expired
- 1977-05-06 ES ES458559A patent/ES458559A1/es not_active Expired
- 1977-05-06 CA CA277,850A patent/CA1091581A/fr not_active Expired
- 1977-05-06 IT IT68021/77A patent/IT1143808B/it active
- 1977-05-06 CH CH572677A patent/CH620587A5/fr not_active IP Right Cessation
- 1977-05-06 US US05/794,646 patent/US4187291A/en not_active Expired - Lifetime
- 1977-05-06 DE DE2720510A patent/DE2720510C2/de not_active Expired
- 1977-05-06 BE BE177354A patent/BE854358A/xx not_active IP Right Cessation
- 1977-05-06 FR FR7713848A patent/FR2362635A1/fr active Granted

Also Published As

Publication number	Publication date
DE2720510A1 (de)	1977-11-24
GB1575217A (en)	1980-09-17
BE854358A (fr)	1977-11-07
JPS539328A (en)	1978-01-27
ES458559A1 (es)	1978-04-16
LU74900A1 (de)	1977-12-13
IT1143808B (it)	1986-10-22
FR2362635A1 (fr)	1978-03-24
DE2720510C2 (de)	1982-10-14
CA1091581A (fr)	1980-12-16
US4187291A (en)	1980-02-05
FR2362635B1 (de)	1980-06-13

Legal Events

Date	Code	Title	Description
1986-01-31	PL	Patent ceased
2024-10-31	PL	Patent ceased

Publication	Publication Date	Title
CA1138739A (fr)	1983-01-04	Composition demaquillante pour le visage et les yeux
CA2023810C (fr)	2003-04-08	Compositions pharmaceutiques de type "pates a l'eau"
EP0577718B1 (de)	1996-06-19	Verwendung von Sphingolipid zur Bereitung einer kosmetiscen oder hautpharmazeutischen Zusammensetzung zum Schützen von Haut und Haaren gegen die durch Luftverschmutzung induzierte schädliche Ergebnisse
CA1274178A (fr)	1990-09-18	L'utilisation de la 2,3-indolinedione pour la coloration des fibres keratiniques
EP2821386B1 (de)	2022-08-17	Kosmetische, dermatologische oder pharmazeutische Zusammensetzung enthaltend wenigstens ein Vanillinderivate als Konservierungsmittel
CH657987A5 (fr)	1986-10-15	Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un autre principe actif.
CA2024086A1 (fr)	1991-03-01	Association de dihydroxyacetone et de derives indoliques pour conferer a la peau une coloration similaire au bronzage naturel et procede de mise en oeuvre
EP0456545B1 (de)	1993-12-15	Zusammensetzung von Dihydroxyaceton und Monohydroxyindolen, um der Haut eine der natürlichen Sonnenbräune ähnliche Farbe zu verleihen, Vorrichtung mit mehreren Fächern und Verfahren zu deren Anwendung
CA1091581A (fr)	1980-12-16	Composition cosmetique a action amincissante et anticellulitique
EP0835650B1 (de)	1999-07-21	Verwendung von Oxazolidinon-Derivaten als penetrations-verhindernde Mittel in einer kosmetischen und/oder dermatologischen Zusammensetzung
WO1997045101A1 (fr)	1997-12-04	UTILISATION D'α-ALKYLGLUCOSIDES ET D'ESTERS D'α-ALKYLGLUCOSIDES EN TANT QU'AGENTS EMULSIONNANTS ANTI-MICROBIENS
JPH11286423A (ja)	1999-10-19	体臭抑制用組成物
FR2674127A1 (fr)	1992-09-25	Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
EP0709081A1 (de)	1996-05-01	Eine Dihydroxyacetonvorläufer enthaltende Zubereitung
FR2673103A1 (fr)	1992-08-28	Association de dihydroxyacetone et de derives indoliques disubstitues pour conferer a la peau une coloration similaire au bronzage naturel, procede et agents de coloration.
EP0820763A2 (de)	1998-01-28	Verwendung von N,N'-Dibenzyl-ethylene diamine saure-Derivaten als Depigmentierungsagentien
FR2965477A1 (fr)	2012-04-06	Utilisation de cannabidiol contre les desequilibres de la microflore cutanee
EP0780120B1 (de)	1998-07-08	Verwendung von Procystein als depigmentierendes Mittel
US5190758A (en)	1993-03-02	Sebaceous excitosecretory agent
JP2000178195A (ja)	2000-06-27	２―アミノ―４―アルキルアミノピリミジン―３―オキシド類からなる鎮静剤
FR2809002A1 (fr)	2001-11-23	Utilisation de derives de l'acide n,n'-dibenzyl ethylene diamine n,n'-diacetique comme agent anti-pollution
EP0771187A1 (de)	1997-05-07	Durch kombination eines antimykotischen mittels und crotamiton als verstärker für antimykotisch effekt enthaltendes neues produkt und dieses enthaltende kosmetische und/oder dermatologische zusammensetzung
EP2509570A1 (de)	2012-10-17	Verwendung von benzyloxy-ethylaminderivaten als konservierungsstoff, konservierungsverfahren und zusammensetzungen
WO2002034222A1 (fr)	2002-05-02	Utilisation de derives du 1,3-diphenylpropane comme actifs inhibant le developpement des odeurs corporelles dans les compositions cosmetiques
FR3115197A1 (fr)	2022-04-22	Composition cosmétique nettoyante comprenant des tensioactifs